Shareholders that lost money on Verve Therapeutics, Inc.(VERV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 09/18/24
Investors in Verve Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights – VERVAccesswire • 09/17/24
VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action LawsuitGlobeNewsWire • 09/17/24
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERVGlobeNewsWire • 09/17/24
Verve Therapeutics Inc May Have Violated Securities Regulations And Shareholders With Losses Should Contact The Schall Law FirmAccesswire • 09/17/24
Lost Money on Verve Therapeutics, Inc. (VERV)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyGlobeNewsWire • 09/16/24
Verve Therapeutics Inc Is Being Sued For Possible Securities Related Infractions And Shareholders Are Invited To Help The Schall Law FirmAccesswire • 09/15/24
The Schall Law Firm Urges Investors To Join A Securities Fraud Case Against Verve Therapeutics, Inc.Accesswire • 09/14/24
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERVGlobeNewsWire • 09/13/24
Verve Therapeutics Inc Is Being Sued For Securities Related Infractions And Stockholders Are Encouraged To Contact The Schall Law FirmAccesswire • 09/13/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/13/24
The Schall Law Firm Urges Shareholder Participation In A Lawsuit Against Verve Therapeutics, Inc. For Securities FraudAccesswire • 09/12/24
VERV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 09/12/24
Verve Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights – VERVAccesswire • 09/11/24
Verve Therapeutics Inc Is Being Sued For Possibly Violating Securities Laws And Investors Are Invited By The Schall Law Firm To Reach OutAccesswire • 09/11/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Verve Therapeutics, Inc. to Contact the Firm Today!Accesswire • 09/11/24
Levi & Korsinsky Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – VERVAccesswire • 09/10/24
Shareholder Rights Attorneys Robbins LLP Reminds VERV Stockholders of the Opportunity to Lead the Verve Therapeutics, Inc. Class ActionBusiness Wire • 09/10/24
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics, Inc. Lawsuit – VERVGlobeNewsWire • 09/10/24
Shareholders That Lost Money on Verve Therapeutics, Inc. (VERV) Should Contact Levi & Korsinsky About Pending Class Action - VERVAccesswire • 09/10/24
A Case For Fraud Has Been Filed Against Verve Therapeutics, Inc. And The Schall Law Firm Urges Stakeholders To Take PartAccesswire • 09/10/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Verve Therapeutics, Inc. to Contact the Firm Today!Accesswire • 09/10/24
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics Lawsuit – VERVAccesswire • 09/09/24
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Verve Therapeutics, Inc. (NASDAQ: VERV); Investors with Losses Encouraged to Discuss Their Options with CounselGlobeNewsWire • 09/09/24
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERVGlobeNewsWire • 09/09/24
